Concurrent Training in Patients Undergoing Atrial Fibrillation Ablation.

Recruiting N/A Interventional Study
Atrial Fibrillation (AF) Physical Exercise Physical Activity Physical Fitness Sleep Quality of Life Electrocardiogram Echocardiogram
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
120 (estimated)
Sponsor
Marcos Echevarría · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation (AF) is an irregular and often very fast heart rhythm, is considered the most common sustained cardiac arrhythmia in adults worldwide, and its incidence and prevalence are increasing. Currently, the estimated prevalence of AF in adults is 2-4%, and is projected to increase 2.3-fold. AF is associated with increased morbimortality and other comorbidities (hypertension diabetes e…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged ≥18 years * Undergoing catheter ablation as medical treatment for AF at least one year prior to enrollment. Exclusion Criteria: * Patients who do not sign the informed consent for participation in the study. * Severe atrial dilatation. * Structural heart diseas…
Contacts

Marcos Echevarría Polo, PhD Student

+34 640554122

mechevarria@unizar.es

CONTACT

Nuria Garatachea Vallejo, PhD

+34 606777435

nugarata@unizar.es

CONTACT